The way we use patient data is changing: We aim to provide the highest quality care. To do this, we routinely collect information about you and the care you receive from us. Like other hospitals across England, we are changing how we share and use this data… Find out more
Pain management
This leaflet will provide you with information about what to expect when you come in for a local steroid injection.
The injections are of steroid and local anaesthetic. They are given into specific areas causing pain around joints and soft tissues. Soft tissues are the tissues surrounding joints.
We use local steroid joint and soft tissue injections to try to reduce pain due to arthritis or soft tissue inflammation when the pain is not adequately controlled by other measures.
These injections are not a cure but many patients find them useful in relieving their symptoms for several weeks and sometimes months.
Your treatment will be at Russells Hall Hospital or Corbett Outpatient Centre as an outpatient in the Day Surgery Unit (either a morning or an afternoon appointment). This will be confirmed at your clinic appointment.
No. A local steroid injection is not treatment that you have to have, but it may help where other forms of treatment have not achieved sufficient relief.
There is no guarantee that the injection will help your symptoms. Side effects following a joint or soft tissue injection are uncommon and potentially serious complications are rare.
Rare complications include:
Occasional complications include:
Side effects such as those seen with regular steroid treatment (e.g. weight gain, osteoporosis) are rare with local steroid injections unless they are given frequently.
If you have any concerns either before or after having the injection, please contact us on the Pain Management helpline: 01384 244735.
Please tell the practitioner before having the injection if:
What if I am taking warfarin or other blood-thinning medication?
The risk of bleeding into a joint after a local injection if you are on warfarin is very small if your warfarin dose and warfarin blood tests are stable (INR less than three), and there is usually no need to discontinue warfarin before the injection.
The anticoagulation clinic will call you to attend the clinic approximately one week before your injection to check your warfarin blood test/INR and adjust your warfarin dose, if necessary. You will also be asked to attend the anticoagulation clinic on the day of your joint injection, before the injection is carried out, for a finger prick blood sample.
The result from this sample is available in seconds and will be written in your anticoagulation book (yellow book). You will be asked to take the book back to the injection clinic. If your INR is less than three, the injection will be carried out. If the INR is higher than three, the injection will be postponed and your warfarin dose will be adjusted to bring your INR down.
Occasionally, for medical reasons, your warfarin dose is adjusted to run the target INR greater than three. In this situation, your doctor will decide on the safest course of action regarding your warfarin doses and INR target around the time of the injection.
If you are on tablets such as Xarelto® (rivaroxaban), Eliquis® (apixaban), Lixiana® (edoxaban), Pradaxa® (dabigatran), or similar, for an irregular heartbeat (atrial fibrillation):
These tablets need to be stopped for a short period before your injection to minimise the risk of bleeding into the joint. Usually, we need to wait at least 24 hours after the last tablet you have taken before performing your injection, and in some cases up to three days is required. Please ask your nurse or doctor for more information.
If the doctor or nurse you saw when the decision for injection was made did not advise you about when to stop this type of medication, please ring the clinical nurse specialists on the Pain Management helpline 01384 244735 for advice, in good time before your appointment.
If you are on any of these medications due to a deep vein or lung blood clot (deep vein thrombosis or pulmonary embolism), and/or are known to have impaired kidney function, the benefits from having the injection over the risks (bleeding into the joint or further blood clots) are a lot less clear. We will need to discuss this with you.
If the blood-thinning treatment for this reason is for a limited time only, it would be safest to consider putting off the injection until your blood-thinning treatment has finished.
We will advise you to remain seated in the Day Case Unit for 30 minutes after the injection for observation to ensure that you have completely recovered following the injection.
You should not drive yourself home after an injection so please arrange for someone to drive you. If you have an injection in your leg, a wheel chair (and if necessary a porter) will be provided to take you back to the car.
We advise you to rest the affected joint(s) as much as possible for 48 hours after the injection before gently returning to normal activity. Resting the joint(s) may help to achieve maximum benefit from the injection.
You may find that your pain is worse straight after you have had the injection. This should subside over the next few days and you are advised to take painkillers as normal. If the pain persists, you can call the helpline number (at the end of the information sheet), or contact your GP for advice.
In the unlikely event that you feel generally unwell after a local steroid injection, please contact your GP immediately.
Arthritis Research UK has a range of information relating to methods of controlling pain in arthritis on their website:
http://www.arthritisresearchuk.org/arthritis-information
If you have any questions, or if there is anything you do not understand, please contact the Russells Hall Hospital switchboard number on 01384 456111 and ask for the relevant department who issued this leaflet.
If you have any feedback on this patient information leaflet please email dgft.patient.information@nhs.net
This leaflet can be made available in large print, audio version and in other languages, please call 0800 073 0510.
Originator: Ruth Carter, Alifia Tameem. Date originated: July 2017. Date reviewed: July 2025 . Next review date: July 2028. Version: 3. DGH ref: DGH/PIL/01371.